期刊文献+

转化生长因子-β_1单克隆抗体对大鼠肺纤维化的治疗观察 被引量:18

The therapeutic effect of TGFβ monoclonal antibody to bleomycininduced pulmonary fibrosis in rats
原文传递
导出
摘要 目的探讨转化生长因子-β(TGF-β)单克隆抗体对博莱霉素所致肺间质纤维化的作用。方法结合体内和体外实验,利用3H-胸腺嘧啶核苷(3H-TdR)掺入法和Northern杂交法。结果表明大鼠肺纤维化模型中肺泡巨噬细胞的条件培养基能促进成纤维细胞的增殖和胶原mRNA的表达。TGF-β1单克隆抗体对其有抑制作用,同时亦能减轻肺组织的病变程度和胶原mRNA的表达。结论TGF-β1单克隆抗体可部分地抑制成纤维细胞增殖和胶原合成。 Objective Transforming growth factorβ(TGFβ) plays an important role in the pathogenesis of interstitial lung fibrosis. It can stimulate indirectly the mitosis of lung fibroblasts (LFb) as well as the synthesis and disposition of extracellular matrix. The purpose of this study was to evaluate the effects of TGFβ monoclonal antibody on bleomycininduced interstitial pulmonary fibrosis. Method The effect of TGFβ monoclonal antibody to bleomycininduced pulmonary fibrosis in rat was studied either in vivo or in vitro. The proliferation of lung fibroblasts was studied by measuring the incorporation rate of 3HTdR. Northern hybridization was used to detect mRNA level of procollagen A1(Ⅰ) and procollagen A1(Ⅲ) in cultured LFbs and lung tissue. Result The results showed that the incubation supernatant of alveolar macrophages from rats with pulmonary fibrosis had the ability to stimulate fibroblast proliferation as well as their procollagen expression. The monoclonal antibody could inhibit the proliferation of LFbs in a concentrationdependent manner. The highest concentration, 100 μg/ml, of TGFβ antibody could inhibit incorporation rate from 1749±322 of the fibrosis group to only 833±277 (P<0.01). The mRNA level of procollagen Ⅰ and Ⅲ was decreased by 44% and 28% respectively after the antibody treatment. In vivo, procollagen Ⅰ and Ⅲ mRNA level were decreased by 40% and 12% after the administration of TGFβ antibody though it could only slightly alleviate the extent of fibrosis and alveolitis in lung tissue. Conclusion TGFβ is a key factor stimulating the proliferation and collagen synthesis. TGFβ antibody can partially neutralize its action. This may suggest that the antibody might become a new therapeutic choice for pulmonary fibrosis in the future.
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 1997年第6期347-349,共3页 Chinese Journal of Tuberculosis and Respiratory Diseases
基金 卫生部课题基金
关键词 肺纤维化 治疗 TGF-B 单克隆抗体 Transforming growth factorβ Interstitial pulmonary fibrosis Antibody
  • 相关文献

同被引文献222

引证文献18

二级引证文献103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部